We provide you with 20 years of free, institutional-grade data for LIPO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of LIPO. Explore the full financial landscape of LIPO stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about LIPO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Lipella Pharmaceuticals Inc.(NASDAQ:LIPO) 
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinic...
Website: https://www.lipella.com
Founded: 2005
IPO Price: $5.75 (Dec 20, 2022)
Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends